Enamel matrix derivative use seems promising in implant dentistry: Study
Enamel matrix derivative use seems promising in implant dentistry, according to a recent study published in the Materials.
Enamel matrix derivative (Straumann Emdogain, Straumann USA LLC) is an extract of porcine fetal tooth material that can stimulate both soft and hard tissue growth. The material is applied to the denuded root surface and promotes healing via a connective tissue fibre attachment.
Enamel matrix derivative (EMD) has been successfully used for periodontal regeneration in intrabony defects. Recently, its use for peri-implant bone regeneration has also been hypothesized. The aim of this paper is to review preclinical and clinical studies investigating the use of Enamel matrix derivative (EMD) in correspondence with titanium implants, alone or as an adjunct to other biomaterials. Clinical trials and case series with more than five cases were included. Seven in vitro studies evaluated the effect of enamel matrix derivative (EMD), placed on titanium surfaces.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.